NKTX
Nkarta, Inc.
Price Chart
Latest Quote
$3.03
+0.24 (+8.60%)
Current Price
| Previous Close | $2.79 |
| Open | $2.79 |
| Day High | $3.18 |
| Day Low | $2.71 |
| Volume | 949,861 |
Stock Information
| Shares Outstanding | 71.55M |
| Total Debt | $75.00M |
| Cash Equivalents | $230.43M |
| Net Income | $-99.93M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $216.78M |
| EPS (TTM) | $-1.35 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $61.35M |
| Income | $-99.93M |
| Book/sh | $4.01 |
| Cash/sh | $3.22 |
| Employees | 108 |
Financial Ratios
| Quick Ratio | 12.75 |
| Current Ratio | 12.96 |
| Debt/Eq | 26.24 |
Returns & Margins
| ROA | -17.10% |
| ROE | -30.07% |
Ownership
| Insider Ownership | 4.88% |
| Institutional Ownership | 80.56% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.84 |
| P/B | 0.76 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $11.33 |
Technical Indicators
| SMA20 | $2.82 |
| SMA50 | $2.89 |
| SMA200 | $2.31 |
| RSI | 53.23 |
| ATR | 0.2461 |
| Shares Float | 60.45M |
| Short Float | 9.14% |
| Short Ratio | 7.26 |
| Volatility | 0.90 |
| Rel Volume | 1.78 |
Performance History
| Week | +10.58% |
| Month | +0.00% |
| Quarter | +38.99% |
| 6 Months | +72.16% |
| YTD | +62.03% |
| Year | +71.19% |
| 3 Years | -38.79% |
| 5 Years | -87.95% |
| 10 Years | -93.67% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $3.03 | 949,861 |
| 2026-06-22 | $2.79 | 537,500 |
| 2026-06-18 | $2.86 | 569,300 |
| 2026-06-17 | $2.64 | 556,000 |
| 2026-06-16 | $2.62 | 343,300 |
| 2026-06-15 | $2.74 | 470,600 |
| 2026-06-12 | $2.86 | 677,600 |
| 2026-06-11 | $2.76 | 1,174,500 |
| 2026-06-10 | $2.46 | 517,500 |
| 2026-06-09 | $2.45 | 479,500 |
| 2026-06-08 | $2.40 | 407,700 |
| 2026-06-05 | $2.51 | 564,000 |
| 2026-06-04 | $2.77 | 372,200 |
| 2026-06-03 | $2.72 | 480,500 |
| 2026-06-02 | $2.91 | 468,300 |
| 2026-06-01 | $3.14 | 395,600 |
| 2026-05-29 | $3.25 | 342,100 |
| 2026-05-28 | $3.30 | 311,300 |
| 2026-05-27 | $3.19 | 600,100 |
| 2026-05-26 | $3.06 | 461,500 |
About Nkarta, Inc.
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
đ° Latest News
Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation
Simply Wall St. âĸ 2026-05-14T11:12:42Z
NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program
Zacks âĸ 2026-04-17T14:28:00Z
Stock Market Today, Jan. 21: ImmunityBio Rises Again As Short-Sellers Face Losses
Motley Fool âĸ 2026-01-21T22:58:39Z
We Think Nkarta (NASDAQ:NKTX) Needs To Drive Business Growth Carefully
Simply Wall St. âĸ 2025-12-04T12:24:28Z
Will Nkarta (NASDAQ:NKTX) Spend Its Cash Wisely?
Simply Wall St. âĸ 2025-06-27T11:04:01Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $121,997,000 | $128,194,000 | $131,650,000 | $118,955,000 |
| Other Income Expense | $2,419,000 | $87,000 | $42,000 | $-470,000 |
| Other Non Operating Income Expenses | $2,419,000 | $87,000 | $42,000 | $-470,000 |
| Net Non Operating Interest Income Expense | $15,494,000 | $19,317,000 | $14,107,000 | $5,588,000 |
| Operating Expense | $121,997,000 | $128,194,000 | $131,650,000 | $118,955,000 |
| General And Administrative Expense | $31,568,000 | $31,450,000 | $34,877,000 | $28,058,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Net Interest Income | $15,494,000 | $19,317,000 | $14,107,000 | $5,588,000 |
| Interest Income | $15,494,000 | $19,317,000 | $14,107,000 | $5,588,000 |
| Normalized Income | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Net Income From Continuing And Discontinued Operation | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Total Operating Income As Reported | $-121,997,000 | $-128,194,000 | $-131,650,000 | $-118,955,000 |
| Net Income Common Stockholders | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Net Income | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Net Income Including Noncontrolling Interests | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Net Income Continuous Operations | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Pretax Income | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Interest Income Non Operating | $15,494,000 | $19,317,000 | $14,107,000 | $5,588,000 |
| Operating Income | $-121,997,000 | $-128,194,000 | $-131,650,000 | $-118,955,000 |
| Per Share | ||||
| Diluted EPS | $-1.41 | $-1.60 | $-2.40 | $-2.61 |
| Basic EPS | $-1.41 | $-1.60 | $-2.40 | $-2.61 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-112,804,000 | $-119,042,000 | $-125,781,000 | $-116,318,000 |
| Reconciled Depreciation | $9,193,000 | $9,152,000 | $5,869,000 | $2,637,000 |
| EBITDA (Bullshit earnings) | $-112,804,000 | $-119,042,000 | $-125,781,000 | $-116,318,000 |
| EBIT | $-121,997,000 | $-128,194,000 | $-131,650,000 | $-118,955,000 |
| Diluted Average Shares | $73,991,197 | $67,865,323 | $49,014,300 | $43,631,722 |
| Basic Average Shares | $73,991,197 | $67,865,323 | $49,014,300 | $43,631,722 |
| Diluted NI Availto Com Stockholders | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
| Research And Development | $90,429,000 | $96,744,000 | $96,773,000 | $90,897,000 |
| Selling General And Administration | $31,568,000 | $31,450,000 | $34,877,000 | $28,058,000 |
| Other Gand A | $31,568,000 | $31,450,000 | $34,877,000 | $28,058,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $312,325,000 | $407,976,000 | $273,285,000 | $372,207,000 |
| Total Assets | $404,209,000 | $501,203,000 | $378,885,000 | $472,938,000 |
| Total Non Current Assets | $121,697,000 | $227,865,000 | $125,814,000 | $112,250,000 |
| Other Non Current Assets | $4,440,000 | $6,801,000 | $6,539,000 | $4,593,000 |
| Investmentin Financial Assets | $16,107,000 | $110,392,000 | $0 | - |
| Current Assets | $282,512,000 | $273,338,000 | $253,071,000 | $360,688,000 |
| Other Current Assets | $2,414,000 | $2,735,000 | $1,619,000 | $2,929,000 |
| Prepaid Assets | $3,819,000 | $3,249,000 | $3,263,000 | $5,616,000 |
| Cash Cash Equivalents And Short Term Investments | $276,279,000 | $267,354,000 | $248,189,000 | $352,143,000 |
| Cash And Cash Equivalents | $39,634,000 | $27,873,000 | $31,040,000 | $37,494,000 |
| Debt | ||||
| Total Debt | $76,420,000 | $80,273,000 | $88,339,000 | $82,934,000 |
| Long Term Debt And Capital Lease Obligation | $69,531,000 | $74,223,000 | $82,270,000 | $78,685,000 |
| Current Debt And Capital Lease Obligation | $6,889,000 | $6,050,000 | $6,069,000 | $4,249,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $91,884,000 | $93,227,000 | $105,600,000 | $100,731,000 |
| Total Non Current Liabilities Net Minority Interest | $69,618,000 | $74,310,000 | $82,270,000 | $78,685,000 |
| Other Non Current Liabilities | $87,000 | $87,000 | - | - |
| Current Liabilities | $22,266,000 | $18,917,000 | $23,330,000 | $22,046,000 |
| Payables And Accrued Expenses | $9,312,000 | $4,949,000 | $10,539,000 | $11,106,000 |
| Payables | $2,089,000 | $638,000 | $3,665,000 | $1,761,000 |
| Accounts Payable | $2,089,000 | $638,000 | $3,665,000 | $1,761,000 |
| Equity | ||||
| Common Stock Equity | $312,318,000 | $407,969,000 | $273,285,000 | $372,207,000 |
| Preferred Stock Equity | $7,000 | $7,000 | - | - |
| Total Equity Gross Minority Interest | $312,325,000 | $407,976,000 | $273,285,000 | $372,207,000 |
| Stockholders Equity | $312,325,000 | $407,976,000 | $273,285,000 | $372,207,000 |
| Gains Losses Not Affecting Retained Earnings | $407,000 | $674,000 | $8,000 | $-679,000 |
| Other Equity Adjustments | $407,000 | $674,000 | $8,000 | $-679,000 |
| Retained Earnings | $-648,308,000 | $-544,224,000 | $-435,434,000 | $-317,933,000 |
| Other | ||||
| Ordinary Shares Number | $71,078,531 | $70,645,139 | $49,181,295 | $48,877,806 |
| Share Issued | $71,078,531 | $70,645,139 | $49,181,295 | $48,877,806 |
| Tangible Book Value | $312,318,000 | $407,969,000 | $273,285,000 | $372,207,000 |
| Invested Capital | $312,318,000 | $407,969,000 | $273,285,000 | $372,207,000 |
| Working Capital | $260,246,000 | $254,421,000 | $229,741,000 | $338,642,000 |
| Capital Lease Obligations | $76,420,000 | $80,273,000 | $88,339,000 | $82,934,000 |
| Total Capitalization | $312,325,000 | $407,976,000 | $273,285,000 | $372,207,000 |
| Additional Paid In Capital | $960,219,000 | $951,519,000 | $708,706,000 | $690,814,000 |
| Capital Stock | $7,000 | $7,000 | $5,000 | $5,000 |
| Common Stock | $0 | $0 | $5,000 | $5,000 |
| Preferred Stock | $7,000 | $7,000 | $0 | $0 |
| Long Term Capital Lease Obligation | $69,531,000 | $74,223,000 | $82,270,000 | $78,685,000 |
| Current Capital Lease Obligation | $6,889,000 | $6,050,000 | $6,069,000 | $4,249,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $6,065,000 | $7,918,000 | $6,722,000 | $6,691,000 |
| Current Accrued Expenses | $7,223,000 | $4,311,000 | $6,874,000 | $9,345,000 |
| Investments And Advances | $16,107,000 | $110,392,000 | $0 | - |
| Available For Sale Securities | $16,107,000 | $110,392,000 | - | - |
| Net PPE | $101,150,000 | $110,672,000 | $119,275,000 | $107,657,000 |
| Accumulated Depreciation | $-28,951,000 | $-20,845,000 | $-11,693,000 | $-5,824,000 |
| Gross PPE | $130,101,000 | $131,517,000 | $130,968,000 | $113,481,000 |
| Leases | $66,487,000 | $66,618,000 | $66,618,000 | $4,402,000 |
| Construction In Progress | $10,568,000 | $10,821,000 | $8,954,000 | $49,655,000 |
| Other Properties | $52,005,000 | $52,928,000 | $54,247,000 | $58,649,000 |
| Machinery Furniture Equipment | $1,041,000 | $1,150,000 | $1,149,000 | $775,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $236,645,000 | $239,481,000 | $217,149,000 | $314,649,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-89,907,000 | $-104,105,000 | $-114,307,000 | $-104,111,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-88,699,000 | $-99,696,000 | $-86,160,000 | $-57,000,000 |
| Cash Flow From Continuing Operating Activities | $-88,699,000 | $-99,696,000 | $-86,160,000 | $-57,000,000 |
| Operating Gains Losses | $-94,000 | - | $-34,000 | $490,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,208,000 | $-4,409,000 | $-28,147,000 | $-47,111,000 |
| Investing Cash Flow | $100,319,000 | $-129,555,000 | $79,015,000 | $-184,689,000 |
| Cash Flow From Continuing Investing Activities | $100,319,000 | $-129,555,000 | $79,015,000 | $-184,689,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $225,073,000 | $0 | $217,170,000 |
| Financing Cash Flow | $141,000 | $226,084,000 | $691,000 | $219,012,000 |
| Cash Flow From Continuing Financing Activities | $141,000 | $226,084,000 | $691,000 | $219,012,000 |
| Net Common Stock Issuance | $0 | $225,073,000 | $0 | $217,170,000 |
| Common Stock Issuance | $0 | $225,073,000 | $0 | $217,170,000 |
| Net Other Financing Charges | - | - | - | - |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| End Cash Position | $42,377,000 | $30,616,000 | $33,783,000 | $40,237,000 |
| Beginning Cash Position | $30,616,000 | $33,783,000 | $40,237,000 | $62,914,000 |
| Changes In Cash | $11,761,000 | $-3,167,000 | $-6,454,000 | $-22,677,000 |
| Proceeds From Stock Option Exercised | $141,000 | $1,011,000 | $691,000 | $1,842,000 |
| Net Investment Purchase And Sale | $101,527,000 | $-125,146,000 | $107,162,000 | $-137,578,000 |
| Sale Of Investment | $340,092,000 | $281,230,000 | $367,395,000 | $248,309,000 |
| Purchase Of Investment | $-238,565,000 | $-406,376,000 | $-260,233,000 | $-385,887,000 |
| Net PPE Purchase And Sale | $-1,208,000 | $-4,409,000 | $-28,147,000 | $-47,111,000 |
| Purchase Of PPE | $-1,208,000 | $-4,409,000 | $-28,147,000 | $-47,111,000 |
| Change In Working Capital | $-435,000 | $-12,163,000 | $10,925,000 | $33,737,000 |
| Change In Other Current Liabilities | $-5,011,000 | $-6,329,000 | $4,986,000 | $32,469,000 |
| Change In Payables And Accrued Expense | $2,463,000 | $-4,469,000 | $4,223,000 | $2,757,000 |
| Change In Payable | $2,463,000 | $-4,469,000 | $4,223,000 | $2,757,000 |
| Change In Account Payable | $2,463,000 | $-4,469,000 | $4,223,000 | $2,757,000 |
| Change In Prepaid Assets | $2,113,000 | $-1,365,000 | $1,716,000 | $-1,489,000 |
| Other Non Cash Items | $1,951,000 | $2,286,000 | $2,222,000 | $3,935,000 |
| Stock Based Compensation | $8,559,000 | $16,731,000 | $17,199,000 | $16,856,000 |
| Asset Impairment Charge | $791,000 | $0 | $4,100,000 | $0 |
| Amortization Of Securities | $-4,580,000 | $-6,912,000 | $-8,940,000 | $-818,000 |
| Depreciation Amortization Depletion | $9,193,000 | $9,152,000 | $5,869,000 | $2,637,000 |
| Depreciation And Amortization | $9,193,000 | $9,152,000 | $5,869,000 | $2,637,000 |
| Gain Loss On Investment Securities | $-94,000 | - | $-34,000 | $490,000 |
| Net Income From Continuing Operations | $-104,084,000 | $-108,790,000 | $-117,501,000 | $-113,837,000 |
Fetched: 2026-06-18